Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Multicenter Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy in the Management of Brain Metastases

NCT07437820 is registered in ClinicalTrials.gov with GCS Ramsay Santé pour l'Enseignement et la Recherche as lead sponsor.

NCT NCT07437820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Multicenter Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy in the Management of Brain Metastases
Lead sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
June 30, 2030
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult